The award aims to enable scientists and clinicians to deepen understanding of key cellular processes linked to metabolism, aging, and disease, areas where accurate measurement has long been a limiting factor. By providing access to NADMED’s metabolomics platform, the initiative supports discovery and collaboration that could shape the next generation of biomedical innovation, the company states.

Related article

NADMED raises EUR 3.5 million

NADMED has closed a series A round to fund its entry into the U.S. and other international markets with its nicotinamide adenine dinucleotide (NAD) measurement technology that may help clinicians establish more precise and personalized treatments for various diseases. The round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional funding was secured […]

The dynamics of redox metabolism

“The goal of the NADMED Award is to lower the barriers for scientists to explore what has until now been largely invisible in biology: the dynamics of redox metabolism,” says Kai Herdin, Chief Marketing Officer at NADMED. “By making our tools available to the research community, we want to accelerate discoveries that could transform how we understand cellular function and disease.”

Reviewed by a scientific jury of global experts

The NADMED Award 2026 is open to academic institutions, clinical laboratories, pharmaceutical companies, and biotech innovators worldwide. Submissions will be reviewed by a scientific jury of global experts, including Prof. Charles Brenner (City of Hope) and Prof. Rita Horvath, Professor of Neurogenetics and Director of Clinical Neurosciences at the University of Cambridge. Selected projects will receive CE-marked metabolomics kits, consultation, and in-house measurement services valued at up to USD 30,000.

Related article

My Nordic Corner: Helsinki

Jari Närhi, CEO of NADMED, describes the life science environment in Helsinki and shares his favorite spots. Describe the vibe in Helsinki for a company like yours! “Helsinki has wonderful tightly-knit startup and deep scientific communities that provide a great environment to develop novel, cutting-edge technologies and applications in biotech and medtech. The city is […]

Three categories

The award features three categories: Innovative Ideas, Advanced Research, and Clinical Data Research. The categories are designed to support projects at different stages of development, from early exploration to clinically focused studies. Applications open January 1–31, 2026, with results announced February 28, 2026.

Applications open January 1–31, 2026, with results announced February 28, 2026.

Key dates:
* Application templates available: December 15, 2025
* Application period: January 1–31, 2026
* Decision announcement: February 28, 2026
* Project support period: March 2026 – March 2027